Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Iambic Therapeutics, Inc. See All Filings	D	2025-11-21 11:25:23 UTC
Amount To Be Raised $124,999,970 Associated Brokers / Dealers N/A CIK Number 0001997038 Filed Document 0001997038-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-11-21 11:25:23 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Iambic Therapeutics, Inc. See All Filings	D/A	2024-06-06 12:01:56 UTC
Amount To Be Raised $49,999,998 Associated Brokers / Dealers N/A CIK Number 0001997038 Filed Document 0001997038-24-000003 Exclusions or Exemptions 506b Accepted Date 2024-06-06 12:01:56 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Iambic Therapeutics, Inc. See All Filings	D/A	2024-05-07 16:19:03 UTC
Amount To Be Raised $37,999,999 Associated Brokers / Dealers N/A CIK Number 0001997038 Filed Document 0001997038-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-05-07 16:19:03 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Iambic Therapeutics, Inc. See All Filings	D	2024-04-25 15:20:14 UTC
Amount To Be Raised $37,999,999 Associated Brokers / Dealers N/A CIK Number 0001997038 Filed Document 0001997038-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-04-25 15:20:14 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Iambic Therapeutics, Inc. See All Filings	D	2023-10-12 17:03:13 UTC
Amount To Be Raised $109,999,999 Associated Brokers / Dealers N/A CIK Number 0001997038 Filed Document 0001997038-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-10-12 17:03:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity